Scemblix الاتحاد الأوروبي - الأيسلاندية - EMA (European Medicines Agency)

scemblix

novartis europharm limited - asciminib hydrochloride - kyrningahvítblæði, mergbreytilegt, langvinnt, bcr-abl jákvætt - Æxlishemjandi lyf - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.

Pepaxti الاتحاد الأوروبي - الأيسلاندية - EMA (European Medicines Agency)

pepaxti

oncopeptides ab - melphalan flufenamide hydrochloride - mergæxli - Æxlishemjandi lyf - pepaxti is indicated, in combination with dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least three prior lines of therapies, whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one anti-cd38 monoclonal antibody, and who have demonstrated disease progression on or after the last therapy. for patients with a prior autologous stem cell transplantation, the time to progression should be at least 3 years from transplantation (see section 4.

Hexvix Duft og leysir fyrir þvagblöðrulausn 85 mg أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

hexvix duft og leysir fyrir þvagblöðrulausn 85 mg

photocure asa - hexaminolevulinate hydrochloride - duft og leysir fyrir þvagblöðrulausn - 85 mg

Metvix Krem 160 mg/g أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

metvix krem 160 mg/g

galderma nordic ab - methyl aminolevulinate hydrochloride - krem - 160 mg/g

Cleye Augndropar, lausn 0,12 mg/ml أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

cleye augndropar, lausn 0,12 mg/ml

elara pharmaservices europe limited - naphazoline hydrochloride - augndropar, lausn - 0,12 mg/ml